20/20 Ent.

20/20 Ent. specializes in sunglasses and sport sunglasses. These products are designed primarily for eye protection and blocking ultraviolet (UV) radiation, which can help reduce eye strain and potential long-term damage from sun exposure. While they serve a protective function, they are not intended for medical treatment or diagnosis.

20/20 Ent. is based in the United States. Since the company’s devices fall under FDA jurisdiction, their regulatory pathway and compliance requirements are governed by U.S. regulations. The FDA classifies these products as Class I devices, which are generally considered low-risk and subject to general controls, including the 510(k) pathway for market listing.

20/20 Ent.’s devices are listed in the FDA’s 510(k) registry. The 510(k) pathway is used to demonstrate that a device is substantially equivalent to a legally marketed predicate device, ensuring compliance with FDA requirements before commercial distribution. This registry helps regulators and stakeholders verify the device’s classification and compliance status.

20/20 Ent.’s sunglasses and sport sunglasses are classified as Class I devices by the FDA. This classification is based on their intended use—primarily for eye protection and UV radiation blocking—rather than therapeutic intervention. Class I devices are considered the lowest risk and typically require only general controls, such as good manufacturing practices and labeling requirements, to ensure safety and effectiveness.